buspirone has been researched along with Akinetic-Rigid Variant of Huntington Disease in 3 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Excerpt | Relevance | Reference |
---|---|---|
"or s." | 5.72 | The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat. ( Depoortere, R; Jastrzębska-Więsek, M; Kołaczkowski, M; Newman-Tancredi, A; Varney, MA; Wesołowska, A, 2022) |
"or s." | 1.72 | The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat. ( Depoortere, R; Jastrzębska-Więsek, M; Kołaczkowski, M; Newman-Tancredi, A; Varney, MA; Wesołowska, A, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Jastrzębska-Więsek, M | 1 |
Wesołowska, A | 1 |
Kołaczkowski, M | 1 |
Varney, MA | 1 |
Newman-Tancredi, A | 1 |
Depoortere, R | 1 |
Byrne, A | 1 |
Martin, W | 1 |
Hnatko, G | 1 |
Hamner, M | 1 |
Huber, M | 1 |
Gardner, VT | 1 |
3 other studies available for buspirone and Akinetic-Rigid Variant of Huntington Disease
Article | Year |
---|---|
The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Buspirone; Catalepsy; Depres | 2022 |
Beneficial effects of buspirone therapy in Huntington's disease.
Topics: Aggression; Buspirone; Humans; Huntington Disease; Irritable Mood; Male; Middle Aged | 1994 |
Patient with progressive dementia and choreaothetoid movements treated with buspirone.
Topics: Anti-Anxiety Agents; Buspirone; Humans; Huntington Disease; Male; Middle Aged | 1996 |